Ekopak NV
F:7XZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ekopak NV
F:7XZ
|
BE |
|
T
|
Trinity Capital Inc
F:9F7
|
US |
|
36Kr Holdings Inc
NASDAQ:KRKR
|
CN |
|
PTT Oil and Retail Business PCL
SET:OR
|
TH |
|
B
|
Boart Longyear Group Ltd
F:3JO
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
XBER:TKD
|
JP |
|
Medicover AB
OTC:MCVEF
|
SE |
|
Two Harbors Investment Corp
F:2H2
|
US |
|
F
|
Fifth Third Bancorp
DUS:FFH
|
US |
|
M
|
Marchex Inc
XMUN:NHM
|
US |
|
M
|
Marchex Inc
F:NHM
|
US |
|
R
|
Realtech AG
DUS:RTC
|
DE |
|
Medicover AB
LSE:0RPS
|
SE |
|
V
|
Vince Holding Corp
F:VNC1
|
US |
|
A&D Holon Holdings Co Ltd
TSE:7745
|
JP |
|
Skeena Resources Ltd
TSX:SKE
|
CA |
|
M
|
Magellan Health Inc
F:MAH1
|
US |
Wall St Price Targets
7XZ Price Targets Summary
Ekopak NV
According to Wall Street analysts, the average 1-year price target for 7XZ is 5.831 EUR with a low forecast of 5.774 EUR and a high forecast of 6.002 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7XZ's stock price target?
Price Target
5.831
EUR
According to Wall Street analysts, the average 1-year price target for 7XZ is 5.831 EUR with a low forecast of 5.774 EUR and a high forecast of 6.002 EUR.
What is the Revenue forecast for Ekopak NV?
Projected CAGR
25%
Over the last 6 years, the compound annual growth rate for Revenue has been 31%. The projected CAGR for the next 7 years is 25%.
What is the Gross Profit forecast for Ekopak NV?
Projected CAGR
57%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 2 years is 57%.
